BACKGROUND: Hepatic radiation @entity137 restricts irradiation of @entity409 . Better knowledge of hepatic tolerance dose is favourable to gain higher safety and to optimize radiation regimes in radiotherapy of the liver. In this study we sought to determine the hepatic tolerance dose to small volume single fraction high dose rate irradiation. MATERIALS AND METHODS: 23 liver @entity3 were treated by CT-guided interstitial brachytherapy. MRI was performed 3 days, 6, 12 and 24 weeks after therapy. MR-sequences were conducted with T1-w GRE enhanced by hepatocyte-targeted @entity18497 . All MRI data sets were merged with 3D-dosimetry data. The reviewer indicated the border of hypointensity on T1-w images (loss of hepatocyte function) or hyperintensity on T2-w images ( @entity4 ). Based on the volume data, a dose-volume-histogram was calculated. We estimated the threshold dose for @entity4 or function loss as the D90, i.e. the dose achieved in at least 90% of the pseudolesion volume. RESULTS: At six weeks post brachytherapy, the hepatocyte function loss reached its maximum extending to the former 9.4Gy isosurface in median (i.e., >= 9.4Gy dose exposure led to hepatocyte dysfunction). After 12 and 24 weeks, the dysfunctional volume had decreased significantly to a median of 11.4Gy and 14Gy isosurface, respectively, as a result of repair mechanisms. Development of @entity4 was maximal at six weeks post brachytherapy (9.2Gy isosurface in median), and regeneration led to a decrease of the isosurface to a median of 11.3Gy between 6 and 12 weeks. The dose exposure leading to hepatocyte dysfunction was not significantly different from the dose provoking @entity4 . CONCLUSION: @entity99 peaked 6 weeks after small volume irradiation. Ongoing repair was observed up to 6 months. Individual dose sensitivity may differ as demonstrated by a relatively high standard deviation of threshold values in our own as well as all other published data.

Quantitative in vivo assessment of radiation injury of the liver using XXXX enhanced MRI: tolerance dose of small liver volumes.

@entity18497 :: ('MESH:C073590', 'Chemical') :: ['Gd-EOB-DTPA'] @entity137 :: ('MESH:D064420', 'Disease') :: ['toxicity'] @entity4 :: ('MESH:D004487', 'Disease') :: ['edema'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver malignancies'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases'] @entity99 :: ('MESH:D056486', 'Disease') :: ['Hepatic injury']
@entity18497 :: (MESH:C073590,Chemical) :: ['Gd-EOB-DTPA']
